contact us
terms and disclaimers
links
investor information
products
science
company
home
Oct 2012
CANYON PHARMACEUTICALS’ DES...
Jun 2012
KIDNEY DISEASE IS AN IMPORT...
Oct 2011
Canyon Pharmaceuticals Hono...
Aug 2011
DESIRABLE STUDY COMPLETED...
May 2011
Study Finds Desirudin Super...
About Us
Investor Relations
Product Information
© Canyon Pharmaceuticals Group